March 27, 2014
Susan Poorman Blackie Ovarian Cancer Foundation makes inaugural gift of $125,000 to support The University of Texas MD Anderson Cancer Center’s ovarian cancer research
HOUSTON, March 27, 2014 /PRNewswire-USNewswire/ -- The Susan Poorman Blackie Ovarian Cancer Foundation awarded its first research gift of $125,000 to The University of Texas MD Anderson Cancer Center. Funds will support MD Anderson Cancer Center's Ovarian Moon Shots program, evaluating genetic markers to identify the most effective therapeutic approaches for women with ovarian cancer. A portion of the gift will also be used to help fund innovative research on early detection of ovarian cancer.
"We are thrilled to be partnering with MD Anderson on this critically important research," said Buck Dodson, Interim Executive Director for the foundation. "Our mission is to fund innovative, promising cancer research that will change the standard of care for ovarian cancer patients - from detection to treatment to quality of life and survival. This is perfectly aligned with the goals of MD Anderson's Moon Shots program."
According to Anil Sood, M.D., Professor of Gynecologic Oncology & Reproductive Medicine at MD Anderson, "This gift from the Susan Poorman Blackie Ovarian Cancer Foundation will provide us with incredible opportunities to aggressively move forward the work on new approaches for ovarian cancer treatment through MD Anderson's Moon Shots Program."
Each year, approximately 20,000 women in the United States are diagnosed with ovarian cancer. There currently is not an accurate screening test for ovarian cancer; many times there are no symptoms until the disease has progressed to an advanced stage.
The Susan Poorman Blackie Ovarian Cancer Foundation was created in 2013 from the desire to detect ovarian cancer early and treat it successfully. The organization's mission is to empower women with knowledge of ovarian cancer and promote innovative, promising research for early detection and treatment.
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute (NCI). For ten of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey published annually in U.S. News & World Report. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).
SOURCE Susan Poorman Blackie Ovarian Cancer Foundation